Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched Analysis.
Brada LJH, Daamen LA, Magermans LG, Walma MS, Latifi D, van Dam RM, de Hingh IH, Liem MSL, de Meijer VE, Patijn GA, Festen S, Stommel MWJ, Bosscha K, Polée MB, Nio YC, Wessels FJ, de Vries JJJ, van Lienden KP, Bruijnen RC, Busch OR, Koerkamp BG, van Eijck C, Molenaar QI, Wilmink HJW, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group.
Brada LJH, et al. Among authors: nio yc.
Ann Surg. 2021 Nov 1;274(5):729-735. doi: 10.1097/SLA.0000000000005120.
Ann Surg. 2021.
PMID: 34334641